NYSE · Health care

Smith & Nephew PLC (SNN)

Smith & Nephew PLC reported revenue of $6.2B in fiscal 2025, up 6.1% from a year earlier. Net income was $625M, a net margin of 10.1%. At December 31, 2025 it held $557M in cash against $3.1B of debt.

Watch SNN in 60 seconds

Price

$27.08

+0.63% on the day · September 28, 2026

52-week range $26.40 to $37.51

Market cap

$11.5B

Revenue (FY2025)

$6.2B

+6.1% year on year

Net margin

10.1%

What Smith & Nephew PLC does

Smith & Nephew PLC is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker SNN.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$6.2B	$794M	$625M	$0.72	n/a
2024	$5.8B	$657M	$412M	$0.47	n/a
2023	$5.5B	$425M	$263M	$0.30	n/a
2022	$5.2B	$450M	$223M	$0.26	n/a
2021	$5.2B	$593M	$524M	$0.60	n/a
2020	$4.6B	$295M	$448M	$0.51	n/a

Full financial statements: income, balance sheet and cash flow

Where SNN ranks in Health care

Revenue$6.2B

#56 of 742 in Health care · Top 7%

Revenue growth+6.1%

#337 of 529 in Health care · Bottom 36%

Net margin10.1%

#112 of 541 in Health care · Top 21%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

It paid out $330M in cash dividends, 53% of its net income.

Fiscal year	Per share	Paid out	Of profit
2025	n/a	$330M	53%
2024	n/a	$327M	79%
2023	n/a	$327M	124%
2022	n/a	$327M	147%
2021	n/a	$329M	63%
2020	n/a	$328M	73%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Smith & Nephew PLC has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 18, 2026
Foreign issuer update 6-K
September 18, 2026
Foreign issuer update 6-K
September 16, 2026
Foreign issuer update 6-K
September 16, 2026
Foreign issuer update 6-K
September 11, 2026
Foreign issuer update 6-K
September 10, 2026
Securities offering prospectus 424B5
September 10, 2026
Foreign issuer update 6-K
September 10, 2026
Foreign issuer update 6-K
September 10, 2026
Foreign issuer update 6-K
September 9, 2026
Offering term sheet FWP

Recent insider filings (Forms 3, 4 and 144): 1, the latest on February 12, 2021. Insider transactions on SEC

Insider trades

What the people running Smith & Nephew PLC did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SNN

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Cevian Capital II GP Limited13D, may seek influence	14.18%	119,179,419	July 27, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SNN

What does Smith & Nephew PLC do?

Smith & Nephew PLC is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker SNN.

Is Smith & Nephew PLC profitable?

Yes. In fiscal 2025 it reported net income of $625M on revenue of $6.2B, a net margin of 10.1%.

How much revenue does Smith & Nephew PLC make?

In fiscal 2025 Smith & Nephew PLC reported revenue of $6.2B. That is 6.1% more than a year earlier.

When did Smith & Nephew PLC last report?

Its newest filing of any kind is the foreign issuer update from September 18, 2026.

Similar companies

ISRG

Intuitive Surgical Inc

ZBH

Zimmer Biomet Holdings, Inc.

Edwards Lifesciences Corp

Compare SNN with

Compare SNN with any company

Follow SNN

Get an email when Smith & Nephew PLC files with the SEC: results, executive changes, material agreements and annual reports.

Follow SNN: get an email when it files

Where the numbers come from

Financial figures are the values Smith & Nephew PLC tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.